Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/1999
12/16/1999WO1999064457A1 Mammalian sperm protein pkdrej with homology to polycystin-1
12/16/1999WO1999064449A2 Cell-permeable peptide
12/16/1999WO1999064435A1 The human kidney specific gene kk86
12/16/1999WO1999064094A1 Methods of delivering aerosolized polynucleotides to the respiratory tract
12/16/1999WO1999064074A1 Methods and compositions for delivering proteins to macrophage cells and cells of macrophage derived lineage
12/16/1999WO1999064071A1 A method for preparing a carbonized resin dna immunoadsorbent
12/16/1999WO1999064021A1 hCEPR RECEPTOR
12/16/1999WO1999057292A9 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery
12/16/1999WO1999056700A3 Avian polyomavirus vaccines in psittacine birds
12/16/1999WO1999052947A3 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA)
12/16/1999WO1999047556A3 Novel heparin-induced ccn-like molecules and uses therefor
12/16/1999WO1999041368A3 Optimization of immunomodulatory properties of genetic vaccines
12/16/1999WO1999029865A3 A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof
12/16/1999WO1999006540A3 Inhibitors of cell-cycle progression and uses related thereto
12/16/1999CA2680649A1 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells
12/16/1999CA2331372A1 Tankyrase, a trfi binding protein
12/16/1999CA2330229A1 Novel angiotensin receptor, production and use thereof
12/16/1999CA2330211A1 Formulations for electroporation
12/16/1999CA2329947A1 Novel adenoviral vectors for gene therapy
12/16/1999CA2329519A1 In vitro maintenance of hematopoietic stem cells
12/16/1999CA2299678A1 Tgf.beta. rii receptor nucleic sequence, coded peptide, and uses
12/15/1999EP0963758A2 Synthetic polyaminoacid complexes for delivery of nucleic acids to target cells
12/15/1999EP0963441A1 Inactivation of hiv co-receptors as therapy for hiv infection
12/15/1999EP0963440A1 Improved methods for transducing cells
12/15/1999EP0963434A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection
12/15/1999EP0963431A1 NOVEL FabH
12/15/1999EP0963208A1 INHIBITION OF Ii SYNTHESIS
12/15/1999EP0963207A1 Il-12 gene therapy of tumors
12/15/1999EP0963203A2 Mammalian tolloid-like gene and protein
12/15/1999EP0788366B1 Use of 2'-substituted oligonucleotides to down-regulating gene expression
12/15/1999EP0743949B1 Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy
12/15/1999EP0529008B1 Modulation of gene expression through interference with rna secondary structure
12/15/1999CN1238807A Stabilized transient gene expression
12/15/1999CN1238702A Radiolabeled DNA oligonuleotide, method of preparation and therapeutic uses
12/15/1999CN1238697A Use of melanoma differentiation associated gene (mda 7) for reversing cancerous phenotype
12/15/1999CA2274365A1 Compounds and compositions containing them useful for the transfer of active substances into a cell
12/14/1999US6001992 Oligonucleotides which promote apoptosis; anticarcinogenic agents, viricides, and treatment of autoimmune disorders
12/14/1999US6001990 Antisense inhibition of hepatitis C virus
12/14/1999US6001987 Isolated nucleotide sequences associated with Multiple sclerosis
12/14/1999US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999US6001968 Mammalian obese polypeptide; for use in genetic therapy; for the treatment of mammals to control body weight and fat content in mammals; for the detection of modulators of weight control
12/14/1999US6001816 Gene therapy for leptin deficiency
12/14/1999US6001653 Human type 2 RNase H
12/14/1999US6001651 Antisense modulation of LFA-3
12/14/1999US6001647 In vitro growth of functional islets of Langerhans and in vivo uses thereof
12/14/1999US6001644 Mammalian transformation complex comprising a lipid carrier and DNA encoding CFTR
12/14/1999US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease
12/14/1999US6001603 Polynucleotide sequence coding for a staphylococcus enzmatic protein; for diagnosis, treatment and prevention of bacterial infections; bactericides
12/14/1999US6001602 DNA encoding Chlamydia trachomatis isoleucyl tRNA synthetase polypeptides
12/14/1999US6001601 Methionyl tRNA synthetase polynucleotides
12/14/1999US6001596 Growth-associated protease inhibitor heavy chain precursor
12/14/1999US6001591 Recombinant bovine adenoviruses
12/14/1999US6001583 Contacting cell having complex of shc polypeptide/grb-7 adaptor polypeptide with compound that acts intracellularly to disrupt the complex; for prevention, prognostic evaluation, and treatment of cancer especially breast cancer
12/14/1999US6001557 Polycation conjugate coding defective virus which reduces the packaging efficiency virus, a minigene and sequences which allow for efficiect viral infection; for gene therapy
12/14/1999US6001361 For the prevention, treatment and diagnosis of mycobacterial infection, together with adjuvants for use in vaccines or immunotherapy of infectious diseases and cancers; for preventing, treating and detecting tuberculosis
12/14/1999US6001350 Genetic modification of endothelial cells
12/14/1999US6001349 Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
12/14/1999US6000772 Tubulin promoter regulates gene expression in neurons
12/14/1999CA2186526C Method and product for regulating cell responsiveness to external signals
12/14/1999CA2155024C Genetic modification of neural stem cells
12/09/1999WO1999063115A2 Use of cathepsin s in the diagnosis and treatment of endometriosis
12/09/1999WO1999063101A2 Transfected cells and methods for treating diabetes
12/09/1999WO1999063095A1 Nucleic acid vaccines for prevention of flavivirus infection
12/09/1999WO1999063094A2 Nucleotide and protein sequences of gpr1 and methods based thereon
12/09/1999WO1999063089A1 Cyclin e2 genes and proteins
12/09/1999WO1999063081A2 Ion channels
12/09/1999WO1999063080A1 HUMAN HOMOLOGUE OF UNC-53 PROTEIN OF $i(C. ELEGANS)
12/09/1999WO1999063079A1 Endometriosis-associated gene
12/09/1999WO1999063071A2 Method for triggering apoptosis in cells
12/09/1999WO1999062940A2 Methods of altering cardiac cell phenotype
12/09/1999WO1999062592A1 Flow-through electroporation system for ex vivo gene therapy
12/09/1999WO1999062562A1 Prosthetic implant and methods of use for therapeutic gene expression
12/09/1999WO1999062561A2 Gene therapy method
12/09/1999WO1999062548A1 Methods and compositions for diagnosing tauopathies
12/09/1999WO1999062547A1 HUMAN MINOR VAULT PROTEIN p193
12/09/1999WO1999062545A2 GnRH VACCINES FOR SUPPRESSING REPRODUCTIVE BEHAVIOUR IN ANIMALS
12/09/1999WO1999062534A1 IL-6/sIL-6R COMPLEX FOR PROMOTION OF LIVER FUNCTIONS
12/09/1999WO1999062527A1 nrdE
12/09/1999WO1999062526A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
12/09/1999WO1999054445A3 Combination therapy using nucleic acids and conventional drugs
12/09/1999WO1999054444A3 Combination therapy using nucleic acids and radio therapy
12/09/1999WO1999051754A9 Infectious pseudotyped lentiviral vectors lacking matrix protein and uses thereof
12/09/1999WO1999051275A3 Mesenchymal stem cells as immunosuppressants
12/09/1999WO1999047678A3 Interferon alpha plasmids and delivery systems, and methods of making and using the same
12/09/1999WO1999044943A3 Vectors and viruses used in gene therapy
12/09/1999WO1999036536A3 Methods and compositions to alter tissue susceptibility to immune injury, to programmed cell death, and to clearance by the reticuloendothelial system
12/09/1999DE19825494A1 Neuer Angiotensin Rezeptor, Herstellung und Verwendung desselben The same new angiotensin receptor preparation and use
12/09/1999DE19824811A1 Verfahren zur Auslösung von Apoptose in Zellen Method for triggering of apoptosis in cells
12/09/1999CA2334171A1 Gene therapy method
12/09/1999CA2334117A1 Use of cathepsin s in the diagnosis and treatment of endometriosis
12/09/1999CA2333394A1 Flow-through electroporation system for ex vivo gene therapy
12/09/1999CA2330833A1 Human minor vault protein p193
12/09/1999CA2330227A1 Method for triggering apoptosis in cells
12/09/1999CA2330179A1 Human homologue of unc-53 protein of c. elegans
12/09/1999CA2330172A1 Prosthetic implant and methods of use for therapeutic gene expression
12/09/1999CA2329940A1 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
12/09/1999CA2329934A1 Methods of altering cardiac cell phenotype
12/09/1999CA2329527A1 Endometriosis-associated gene
12/09/1999CA2329512A1 Il-6/sil-6r complex for promotion of liver functions
12/08/1999EP0962534A2 Expression vector containing regulatory sequences from an immunoglobulin locus
1 ... 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 ... 870